Ocular Therapeutix, Inc

(NASDAQ:OCUL)

Latest On Ocular Therapeutix, Inc (OCUL):

Date/Time Type Description Signal Details
2023-05-18 23:34 ESTNewsOcular Therapeutix: I Still Don't See The NeedN/A
2023-05-09 02:50 ESTNewsOcular Therapeutix GAAP EPS of -$0.39 misses by $0.12, revenue of $13.37M misses by $0.73MN/A
2023-05-09 02:50 ESTNewsOcular Therapeutix, Inc. (OCUL) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 01:03 ESTNewsOcular Therapeutix Q1 2023 Earnings PreviewN/A
2023-03-07 22:48 ESTNewsOcular Therapeutix stock rises after posting Q4 results beat, strong guidanceN/A
2023-03-07 08:01 ESTNewsOcular Therapeutix, Inc. (OCUL) Q4 2022 Earnings Call TranscriptN/A
2023-03-06 17:33 ESTNewsOcular Therapeutix Q4 GAAP EPS, revenue beats, guidance below consensusN/A
2023-03-06 02:44 ESTNewsOcular Therapeutix Q4 2022 Earnings PreviewN/A
2023-03-04 00:55 ESTNewsOcular Therapeutix: A Promising Turnaround PlayN/A
2023-02-14 11:58 ESTNewsNext Round Of Financing Will Be Transformational For Ocular TherapeutixN/A
2023-02-13 09:49 ESTNewsOcular stock rises ~15% as eye drug implant shows promise in ongoing phase 1 trialN/A
2023-02-12 21:43 ESTNewsOcular Therapeutix: A 'Buy' On Maturing Wet AMD DataN/A
2022-12-12 00:53 ESTNewsOcular Therapeutix: Good Potential, But Not That Good An ExecutionN/A
2022-11-08 16:55 ESTNewsOcular falls 12% as eye therapy Dextenza Q3 sales decline, cuts FY22 outlookN/A
2022-11-08 16:55 ESTNewsOcular Therapeutix hits 52-week low after slashing revenue guidanceN/A
2022-11-07 22:46 ESTNewsOcular Therapeutix GAAP EPS of -$0.31 misses by $0.07, revenue of $11.97M misses by $2.3MN/A
2022-11-07 22:46 ESTNewsOcular Therapeutix, Inc. (OCUL) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 06:22 ESTNewsOcular Therapeutix Q3 2022 Earnings PreviewN/A
2022-09-27 15:05 ESTNewsOcular stock rises as eye drug implant OTX-TKI shows promise in vision disorder in trialN/A
2022-08-22 02:45 ESTNewsOcular Therapeutix: Dextenza Sales Accelerating And Near-Term Catalyst ApproachingN/A
2022-08-15 19:39 ESTNewsOcular Therapeutix: Trading Ahead Of An Underappreciated Catalyst EventN/A
2022-08-09 06:07 ESTNewsOcular Therapeutix GAAP EPS of -$0.25 misses by $0.02, revenue of $12.26M misses by $1.99MN/A
2022-08-09 06:07 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 05:34 ESTNewsOcular Therapeutix Q2 2022 Earnings PreviewN/A
2022-05-10 11:19 ESTNewsOcular Therapeutix GAAP EPS of -$0.22 beats by $0.03, revenue of $13.19M misses by $0.77MN/A
2022-05-10 11:18 ESTNewsOcular Therapeutix's (OCUL) CEO Antony Mattessich on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-07 05:46 ESTNewsOcular Therapeutix Q1 2022 Earnings PreviewN/A
2022-03-29 07:01 ESTNewsOcular Therapeutix: A Follow-UpN/A
2022-03-08 17:48 ESTNewsOcular Therapeutix: Transformative Year Ahead Full Of Important MilestonesN/A
2022-03-01 10:49 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 16:33 ESTNewsOcular Therapeutix GAAP EPS of -$0.23 in-line, revenue of $12.31M misses by $2.13MN/A
2022-02-27 21:16 ESTNewsOcular Therapeutix Q4 2021 Earnings PreviewN/A
2022-01-19 15:59 ESTNewsOcular Therapeutix owner buys 50,000 shares worth ~$300KN/A
2022-01-19 00:54 ESTNewsAffaMed Therapeutics begins dosing in China trial of DEXTENZA to treat ocular inflammationN/A
2022-01-08 01:34 ESTNewsOcular Therapeutix: Shaken By Covid, Perfectly Positioned For Long-Term GainsN/A
2021-12-12 09:46 ESTNewsHighlighting Ocular TherapeutixN/A
2021-12-10 00:37 ESTNewsOcular Therapeutix trades high on director acquiring 60.9K sharesN/A
2021-12-08 10:52 ESTNewsWarning: OCUL is at high risk of performing badlyN/A
2021-12-06 20:03 ESTNewsOcular Therapeutix reports positive OTX-DED data in mid-stage dry eye disease studyN/A
2021-11-09 14:12 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-08 16:27 ESTNewsOcular Therapeutix EPS beats by $0.04, misses on revenueN/A
2021-11-07 19:57 ESTNewsOcular Therapeutix Q3 2021 Earnings PreviewN/A
2021-10-24 05:07 ESTNewsMeiraGTx, Aurinia among healthcare gainers this week; Jasper slips after twofold riseN/A
2021-10-22 16:55 ESTNewsOcular Therapeutix posts topline results from mid-stage OTX-CSI dry eye disease trialN/A
2021-10-11 15:36 ESTNewsOcular Therapeutix gains on FDA approval of DEXTENZA for new indicationN/A
2021-10-11 15:36 ESTNewsOyster Point benefits from Ocular sNDA approval; shares up 13%N/A
2021-08-10 09:07 ESTNewsOcular Therapeutix EPS misses by $0.05, beats on revenueN/A
2021-08-10 09:06 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-09 12:28 ESTNewsOcular Therapeutix: Why I'm Buying The DipN/A
2021-08-06 08:09 ESTNewsOcular Therapeutix and Regeneron scrap collaboration agreementN/A

About Ocular Therapeutix, Inc (OCUL):

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant administered by the fine-gauge needle that is in phase 1 clinical trial for the treatment of wet age-related macular degeneration; OTX-TIC, a travoprost intracameral implant, which is in phase 1 clinical trial for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that is in phase 2 clinical trial for the chronic treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trial for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company is involved in the development of OTX-AFS, an aflibercept suprachoroidal injection for the treatment of retinal diseases. It has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

OCUL Quotes by TradingView

See Advanced Chart

General

  • Name Ocular Therapeutix, Inc
  • Symbol OCUL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 181
  • Fiscal Year EndDecember
  • IPO Date2014-07-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.ocutx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 91.26
  • Price/Book (Most Recent Quarter) 124.04
  • Enterprise Value Revenue 87.16
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.69
  • Next Year EPS Estimate -$0.25
  • Next Quarter EPS Estimate -$0.17
  • Operating Margin -361%
  • Return on Assets -23%
  • Return on Equity -430%
  • Revenue 17.4 million
  • Earnings Per Share -$1.79
  • Revenue Per Share $0.29
  • Gross Profit -13374000
  • Quarterly Earnings Growth 225.8%
View More

Highlights

  • Market Capitalization 1.55 billion
  • EBITDA -71014000
  • PE Ratio -9.94
  • Analyst Target Price $25.5
  • Book Value Per Share $1.00
View More

Share Statistics

  • Shares Outstanding 76.07 million
  • Shares Float 66.88 million
  • % Held by Insiders 466%
  • % Held by Institutions 55.42%
  • Shares Short 5.07 million
  • Shares Short Prior Month 4.75 million
  • Short Ratio 4.88
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.19
  • 52 Week High $24.3
  • 52 Week Low $4.09
  • 50 Day Moving Average 19.01
  • 200 Day Moving Average 15.53
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ocular Therapeutix, Inc (OCUL) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ocular Therapeutix, Inc (OCUL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$7.35 million-$0.23-$0.17-35.82%
2020-09-302020-11-05$5.88 million-$0.19-$0.2522.98%
2020-06-302020-08-07$N/A-$0.64-$0.32-97.96%
2020-03-312020-05-08$2.61 million-$0.41-$0.5017.17%
2019-12-312020-03-12$2.26 million-$0.53-$0.42-26.19%
2019-09-302019-11-12$829000-$0.45-$0.462.17%
2019-06-302019-08-07$650000-$0.57-$0.48-17.94%
2019-03-312019-05-10$492000-$0.41-$0.421.2%
2018-12-312019-03-07$504000-$0.42-$0.38-9.38%
2018-09-302018-11-07$498000-$0.38-$0.37-2.7%
2018-06-302018-08-07$648000-$0.37-$0.381.33%
2018-03-312018-05-08$340000-$0.40-$0.412.44%
2017-12-312018-03-08$487000-$0.44-$0.5316.98%
2017-09-302017-11-07$523000-$0.54-$0.53-1.89%
2017-06-302017-08-08$438000-$0.64-$0.57-11.5%
2017-03-312017-05-05$475000-$0.58-$0.48-20.01%
2016-12-312017-03-10$511000-$0.52-$0.46-13.66%
2016-09-302016-11-09$477000-$0.39-$0.5021.61%
2016-06-302016-08-09$441000-$0.46-$0.495.49%
2016-03-312016-05-10$458000-$0.44-$0.43-1.95%
2015-12-312016-03-10$436000-$0.43-$0.479.15%
2015-09-302015-11-10$429000-$0.47-$0.38-23.68%
2015-06-302015-08-10$459000-$0.45-$0.33-36.36%
2015-03-312015-05-15$426000-$0.35-$0.3910.26%
2014-12-312015-03-10$505000-$0.37-$0.382.63%
2014-09-302014-11-12$143000-$0.48-$0.43-11.63%
2014-06-302014-08-29$97000-$2.10

Ocular Therapeutix, Inc (OCUL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ocular Therapeutix, Inc (OCUL) Chart:

Ocular Therapeutix, Inc (OCUL) News:

Below you will find a list of latest news for Ocular Therapeutix, Inc (OCUL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ocular Therapeutix, Inc (OCUL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-192.50CALL0 00TRUE00
2025-09-1953.98CALL0 380TRUE00
2025-09-1960CALL0 0594.53TRUE00
2025-09-197.55.8CALL0 10780TRUE00
2025-09-1990CALL0 0362.91TRUE00
2025-09-19102.89CALL0 3119130.77TRUE00
2025-09-19110CALL0 0188.69TRUE00
2025-09-1912.50.6CALL60 538165.17TRUE-0.15-0.2
2025-09-19140CALL0 0109.04FALSE00
2025-09-19150.15CALL218 4066115.06FALSE0.010.07
2025-09-19160CALL0 0201.74FALSE00
2025-09-1917.50.35CALL0 35256.54FALSE00
2025-09-19190CALL0 0391.46FALSE00
2025-09-19200CALL0 0379.87FALSE00
2025-09-192.50PUT0 01373.36FALSE00
2025-09-1950PUT0 23396.94FALSE00
2025-09-1960PUT0 0674.85FALSE00
2025-09-197.50.12PUT0 81277.77FALSE00
2025-09-1990PUT0 0391.4FALSE00
2025-09-19100.3PUT0 2169261.12FALSE00
2025-09-19110PUT0 0236.01FALSE00
2025-09-1912.50.8PUT0 51264.12FALSE00
2025-09-19140PUT0 089.17TRUE00
2025-09-19152.05PUT0 20TRUE00
2025-09-19160PUT0 0268.99TRUE00
2025-09-1917.54.8PUT0 27172.57TRUE00
2025-09-19190PUT0 0340.3TRUE00
2025-09-19200PUT0 0374.43TRUE00
2025-10-172.50CALL0 00TRUE00
2025-10-1750CALL0 0352.04TRUE00
2025-10-1760CALL0 0286.96TRUE00
2025-10-177.50CALL0 0238.15TRUE00
2025-10-1790CALL0 0150.3TRUE00
2025-10-17103.1CALL0 152967.68TRUE00
2025-10-17110CALL0 070.47TRUE00
2025-10-1712.51.45CALL0 261785.61TRUE00
2025-10-17140CALL0 085.92FALSE00
2025-10-17150.53CALL0 110778.9FALSE00
2025-10-17160CALL0 088.15FALSE00
2025-10-1717.50.25CALL101 5188.07FALSE0.250
2025-10-17190CALL0 096.96FALSE00
2025-10-17200.1CALL0 1111.94FALSE00
2025-10-1722.50CALL0 0181.58FALSE00
2025-10-17250CALL0 0200.72FALSE00
2025-10-172.50PUT0 0578.06FALSE00
2025-10-1750PUT0 0339.5FALSE00
2025-10-1760PUT0 0284.36FALSE00
2025-10-177.50PUT0 0218.71FALSE00
2025-10-1790PUT0 0100.88FALSE00
2025-10-17100.2PUT0 26105.57FALSE00
2025-10-17110PUT0 0100.06FALSE00
2025-10-1712.51.01PUT0 8279.4FALSE00
2025-10-17140PUT0 074.97TRUE00
2025-10-17153.23PUT0 373.99TRUE00
2025-10-17160PUT0 076.15TRUE00
2025-10-1717.50PUT0 077.03TRUE00
2025-10-17190PUT0 0146.14TRUE00
2025-10-17200PUT0 090.95TRUE00
2025-10-1722.50PUT0 0196.02TRUE00
2025-10-17250PUT0 0199.18TRUE00
2025-12-192.50CALL0 0137.42TRUE00
2025-12-1956.76CALL0 40160.46TRUE00
2025-12-197.55.9CALL0 21112.26TRUE00
2025-12-19102.95CALL0 69371.29TRUE00
2025-12-1912.52CALL0 14665.73TRUE00
2025-12-19151CALL0 85160.15FALSE00
2025-12-1917.50.7CALL0 25278.98FALSE00
2025-12-19200CALL0 090.89FALSE00
2025-12-1922.50.18CALL0 580.92FALSE00
2025-12-19250CALL0 0127.95FALSE00
2025-12-192.50PUT0 0343.67FALSE00
2025-12-1950PUT0 23202.13FALSE00
2025-12-197.50.14PUT0 46130.56FALSE00
2025-12-19100.75PUT0 64172.11FALSE00
2025-12-1912.51.6PUT1 12570.06FALSE1.60
2025-12-19154.3PUT0 364.98TRUE00
2025-12-1917.50PUT0 096.3TRUE00
2025-12-19200PUT0 072.06TRUE00
2025-12-1922.50PUT0 081.12TRUE00
2025-12-19250PUT0 00TRUE00
2026-01-162.50CALL0 18231.75TRUE00
2026-01-1636.3CALL0 550TRUE00
2026-01-163.57.5CALL0 54182.47TRUE00
2026-01-1648.5CALL0 57163.97TRUE00
2026-01-164.55CALL0 28154.45TRUE00
2026-01-1658.2CALL0 10893.84TRUE00
2026-01-165.58.1CALL0 7994.08TRUE00
2026-01-1676.13CALL0 209985.78TRUE00
2026-01-1680CALL0 0101.46TRUE00
2026-01-1690CALL0 096.48TRUE00
2026-01-16103.84CALL0 646776.15TRUE00
2026-01-16113.11CALL2 072.24TRUE3.110
2026-01-1612.52.4CALL2 640773.84TRUE2.40
2026-01-16140CALL0 073.44FALSE00
2026-01-16151.45CALL1 379972.25FALSE1.450
2026-01-16161.1CALL1 069.15FALSE1.10
2026-01-1617.51.25CALL0 4376.74FALSE00
2026-01-16190CALL0 080.41FALSE00
2026-01-16200.55CALL0 422381.85FALSE00
2026-01-1622.50.45CALL0 4782.09FALSE00
2026-01-16250CALL0 086.13FALSE00
2026-01-162.50PUT0 7303.32FALSE00
2026-01-1630PUT0 0267.16FALSE00
2026-01-163.50PUT0 0238.78FALSE00
2026-01-1640PUT0 25215.45FALSE00
2026-01-164.50PUT0 3190.52FALSE00
2026-01-1650.1PUT0 35178.51FALSE00
2026-01-165.50.13PUT0 32180.11FALSE00
2026-01-1670.22PUT0 26188.79FALSE00
2026-01-1680PUT0 096.29FALSE00
2026-01-1690PUT0 092.86FALSE00
2026-01-16100.85PUT0 977116.79FALSE00
2026-01-16110PUT0 083.95FALSE00
2026-01-1612.51.85PUT26 59771.03FALSE1.850
2026-01-16140PUT0 071.99TRUE00
2026-01-16153.9PUT0 1273.55TRUE00
2026-01-16160PUT0 070.66TRUE00
2026-01-1617.50PUT0 6072.98TRUE00
2026-01-16190PUT0 065.2TRUE00
2026-01-16200PUT0 0100.24TRUE00
2026-01-1622.50PUT0 0107.57TRUE00
2026-01-16250PUT0 0103.3TRUE00
2026-03-202.50CALL0 0187.34TRUE00
2026-03-2050CALL0 0160.94TRUE00
2026-03-2060CALL0 0130.89TRUE00
2026-03-207.50CALL0 0129.55TRUE00
2026-03-2090CALL0 0117.81TRUE00
2026-03-20104.8CALL0 8113.25TRUE00
2026-03-20110CALL0 091.57TRUE00
2026-03-2012.53.9CALL0 19094.19TRUE00
2026-03-20140CALL0 0103.49FALSE00
2026-03-20153.4CALL0 19699.99FALSE00
2026-03-20160CALL0 0101.22FALSE00
2026-03-2017.52.25CALL0 12297.23FALSE00
2026-03-20190CALL0 095.84FALSE00
2026-03-20202.5CALL0 10795.81FALSE00
2026-03-2022.51.15CALL0 95105.69FALSE00
2026-03-20250CALL0 0107.17FALSE00
2026-03-202.50PUT0 0276.67FALSE00
2026-03-2050PUT0 0172.06FALSE00
2026-03-2060PUT0 0125.96FALSE00
2026-03-207.50.9PUT0 1148.45FALSE00
2026-03-2090PUT0 0102.96FALSE00
2026-03-20102.23PUT0 2108.49FALSE00
2026-03-20110PUT0 0102.4FALSE00
2026-03-2012.53.3PUT0 388129.83FALSE00
2026-03-20140PUT0 0100.66TRUE00
2026-03-20154.8PUT0 23799.65TRUE00
2026-03-20160PUT0 099.15TRUE00
2026-03-2017.50PUT0 096.96TRUE00
2026-03-20190PUT0 093.14TRUE00
2026-03-20200PUT0 094.01TRUE00
2026-03-2022.50PUT0 084.98TRUE00
2026-03-20250PUT0 086.82TRUE00
2026-04-172.50CALL0 0203.17TRUE00
2026-04-1757.5CALL0 12131.82TRUE00
2026-04-1760CALL0 0118.46TRUE00
2026-04-177.56.9CALL0 38115.83TRUE00
2026-04-1790CALL0 0100.15TRUE00
2026-04-17105.19CALL0 1142103.54TRUE00
2026-04-17110CALL0 0103.3TRUE00
2026-04-1712.54CALL0 2125101.42TRUE00
2026-04-17140CALL0 098.85FALSE00
2026-04-17153.4CALL0 11094.89FALSE00
2026-04-17160CALL0 093.49FALSE00
2026-04-1717.52.25CALL0 11388.51FALSE00
2026-04-17190CALL0 0113.46FALSE00
2026-04-17202CALL0 8889.13FALSE00
2026-04-1722.51.05CALL0 46977.02FALSE00
2026-04-17250CALL0 0103.95FALSE00
2026-04-172.50.2PUT0 1258.58FALSE00
2026-04-1750PUT0 0170.92FALSE00
2026-04-1760PUT0 0132.44FALSE00
2026-04-177.51.13PUT0 1080113.32FALSE00
2026-04-1790PUT0 0103.84FALSE00
2026-04-17102.15PUT0 1870125.06FALSE00
2026-04-17110PUT0 0102.08FALSE00
2026-04-1712.53.74PUT0 2102.42FALSE00
2026-04-17140PUT0 097.11TRUE00
2026-04-17154.6PUT0 392.28TRUE00
2026-04-17160PUT0 094.44TRUE00
2026-04-1717.56.17PUT0 693.75TRUE00
2026-04-17190PUT0 089.02TRUE00
2026-04-17200PUT0 085.85TRUE00
2026-04-1722.50PUT0 089.36TRUE00
2026-04-17250PUT0 0105.54TRUE00

Latest OCUL Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$3.57
Jun 13, 2022 7:59 PM EST18$3.565
Jun 13, 2022 7:59 PM EST100$3.57
Jun 13, 2022 7:59 PM EST5$3.565
Jun 13, 2022 7:59 PM EST2$3.565

Ocular Therapeutix, Inc (OCUL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920079714/0001104659-20-079714-index.htm
2019-02-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1393434/000000000019001625/0000000000-19-001625-index.htm
2019-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1393434/000000000019006740/0000000000-19-006740-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000005341719000053/0000053417-19-000053-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000021545719006851/0000215457-19-006851-index.htm
2018-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000031506618002543/0000315066-18-002543-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000031506619001221/0000315066-19-001221-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000083423720006050/0000834237-20-006050-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000083423720009555/0000834237-20-009555-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000008/0000893838-19-000008-index.htm
2019-03-04SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000010/0000893838-19-000010-index.htm
2019-04-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000011/0000893838-19-000011-index.htm
2019-05-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000090514819000611/0000905148-19-000611-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000090514820000304/0000905148-20-000304-index.htm
2018-12-28S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1393434/000104746918007791/0001047469-18-007791-index.htm
2019-04-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1393434/000104746919001837/0001047469-19-001837-index.htm
2019-04-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746919002010/0001047469-19-002010-index.htm
2019-04-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1393434/000104746919002765/0001047469-19-002765-index.htm
2020-05-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746920003131/0001047469-20-003131-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746920003152/0001047469-20-003152-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465918066652/0001104659-18-066652-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918072100/0001104659-18-072100-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918072563/0001104659-18-072563-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918073444/0001104659-18-073444-index.htm
2018-12-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465918075138/0001104659-18-075138-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000887/0001104659-19-000887-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000889/0001104659-19-000889-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000890/0001104659-19-000890-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000891/0001104659-19-000891-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000892/0001104659-19-000892-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000894/0001104659-19-000894-index.htm
2019-01-16DEL AMDelaying amendmenthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919002007/0001104659-19-002007-index.htm
2019-02-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1393434/000110465919006823/0001104659-19-006823-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919009429/0001104659-19-009429-index.htm
2019-02-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919009989/0001104659-19-009989-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919013380/0001104659-19-013380-index.htm
2019-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919013389/0001104659-19-013389-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919014844/0001104659-19-014844-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919015691/0001104659-19-015691-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919015692/0001104659-19-015692-index.htm
2019-03-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016897/0001104659-19-016897-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016898/0001104659-19-016898-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016981/0001104659-19-016981-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919020175/0001104659-19-020175-index.htm
2019-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919023120/0001104659-19-023120-index.htm
2019-04-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1393434/000110465919023739/0001104659-19-023739-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919024896/0001104659-19-024896-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919028431/0001104659-19-028431-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919029753/0001104659-19-029753-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919030555/0001104659-19-030555-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919032737/0001104659-19-032737-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919032741/0001104659-19-032741-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919033292/0001104659-19-033292-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034285/0001104659-19-034285-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034632/0001104659-19-034632-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm
2019-06-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035409/0001104659-19-035409-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035410/0001104659-19-035410-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035411/0001104659-19-035411-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035412/0001104659-19-035412-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035413/0001104659-19-035413-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035414/0001104659-19-035414-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035515/0001104659-19-035515-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036008/0001104659-19-036008-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036009/0001104659-19-036009-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036832/0001104659-19-036832-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919039304/0001104659-19-039304-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919039308/0001104659-19-039308-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919044532/0001104659-19-044532-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919051114/0001104659-19-051114-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919061710/0001104659-19-061710-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919062030/0001104659-19-062030-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009939/0001104659-20-009939-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009941/0001104659-20-009941-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009943/0001104659-20-009943-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009945/0001104659-20-009945-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920012235/0001104659-20-012235-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920021085/0001104659-20-021085-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920028268/0001104659-20-028268-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920032464/0001104659-20-032464-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920032495/0001104659-20-032495-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920045708/0001104659-20-045708-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920051935/0001104659-20-051935-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920058381/0001104659-20-058381-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920061664/0001104659-20-061664-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920065123/0001104659-20-065123-index.htm
2020-06-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000110465920073398/0001104659-20-073398-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077440/0001104659-20-077440-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077441/0001104659-20-077441-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077444/0001104659-20-077444-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077446/0001104659-20-077446-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077448/0001104659-20-077448-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077449/0001104659-20-077449-index.htm
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920079714/0001104659-20-079714-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920080918/0001104659-20-080918-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920083953/0001104659-20-083953-index.htm
2020-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920084290/0001104659-20-084290-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920091724/0001104659-20-091724-index.htm
2020-09-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920108898/0001104659-20-108898-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920112646/0001104659-20-112646-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920112885/0001104659-20-112885-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920114553/0001104659-20-114553-index.htm
2020-10-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000110465920114581/0001104659-20-114581-index.htm
2020-10-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000110465920114906/0001104659-20-114906-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920115475/0001104659-20-115475-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920119750/0001104659-20-119750-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920121801/0001104659-20-121801-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000113777419000037/0001137774-19-000037-index.htm
2020-03-25SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000114036120006856/0001140361-20-006856-index.htm
2020-05-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000114036120012177/0001140361-20-012177-index.htm
2019-03-18DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000139343419000001/0001393434-19-000001-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000141057818000569/0001410578-18-000569-index.htm
2019-05-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000149315219006391/0001493152-19-006391-index.htm
2019-12-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315219019793/0001493152-19-019793-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000167/0001493152-20-000167-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000453/0001493152-20-000453-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220005795/0001493152-20-005795-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837018008793/0001558370-18-008793-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1393434/000155837019001659/0001558370-19-001659-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1393434/000155837019003296/0001558370-19-003296-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000155837019003299/0001558370-19-003299-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019004776/0001558370-19-004776-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019007462/0001558370-19-007462-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019010684/0001558370-19-010684-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1393434/000155837020002537/0001558370-20-002537-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1393434/000155837020004640/0001558370-20-004640-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000155837020004644/0001558370-20-004644-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020005871/0001558370-20-005871-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020009817/0001558370-20-009817-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020012870/0001558370-20-012870-index.htm
2019-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761919006040/0001567619-19-006040-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920010898/0001567619-20-010898-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920017996/0001567619-20-017996-index.htm
2019-02-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1393434/999999999519000194/9999999995-19-000194-index.htm
2019-04-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1393434/999999999519000902/9999999995-19-000902-index.htm
2019-10-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1393434/999999999719007342/9999999997-19-007342-index.htm

Ocular Therapeutix, Inc (OCUL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ocular Therapeutix, Inc (OCUL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 466%
Institutional Ownership: 5542%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-10Kevin F. HanleyOfficerBuy10,000.005.6056,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918072563/0001104659-18-072563-index.htm
2019-03-13RICHARD L MD LINDSTROMDirectorBuy56,441.004.33244,389.53100,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919014844/0001104659-19-014844-index.htm
2019-06-07Amarpreet SawhneyChairman of the BoardBuy65,468.003.02197,713.361,056,031.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm
2019-03-15Michael H. GoldsteinChief Medical OfficerBuy10,000.004.1541,500.0013,686.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919015691/0001104659-19-015691-index.htm
2018-12-14Kevin F. HanleyOfficerBuy10,000.005.5055,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918073444/0001104659-18-073444-index.htm
2019-12-30Opaleye Management Inc.10% Share HolderBuy5,000.003.9719,852.50207,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2019-03-15Jeffrey S. HeierDirectorBuy24,000.004.1599,600.0024,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919015692/0001104659-19-015692-index.htm
2019-06-14Donald NotmanChief Financial OfficerBuy2,500.004.3310,825.0024,049.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919036009/0001104659-19-036009-index.htm
2019-05-28Michael H. GoldsteinChief Medical OfficerBuy12,000.002.5130,120.0025,686.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919032741/0001104659-19-032741-index.htm
2020-03-13SUMMER ROAD LLC10% Share HolderBuy210,800.004.63975,982.924,015,588.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2020-03-16SUMMER ROAD LLC10% Share HolderBuy194,262.004.16807,216.894,209,850.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2018-12-06Daniel M BollagOfficerBuy17,400.005.76100,224.0042,100.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918072100/0001104659-18-072100-index.htm
2019-06-14Leslie J. WilliamsDirectorBuy4,500.004.4019,800.004,500.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919036008/0001104659-19-036008-index.htm
2020-03-17SUMMER ROAD LLC10% Share HolderBuy550,000.004.662,562,890.004,759,850.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2019-12-30Opaleye Management Inc.10% Share HolderBuy15,000.003.9759,557.504,903,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2020-01-02Opaleye Management Inc.10% Share HolderBuy15,000.003.9058,507.504,918,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000167/0001493152-20-000167-index.htm
2020-03-18SUMMER ROAD LLC10% Share HolderBuy344,938.004.621,594,199.955,104,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-19SUMMER ROAD LLC10% Share HolderBuy40,900.004.63189,223.855,145,688.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-20SUMMER ROAD LLC10% Share HolderBuy9,100.004.5241,119.265,154,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-03-23SUMMER ROAD LLC10% Share HolderBuy64,948.004.66302,365.415,219,736.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-03-24SUMMER ROAD LLC10% Share HolderBuy35,052.004.87170,713.765,254,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-05-19SUMMER ROAD LLC10% Share HolderBuy363,636.005.501,999,998.005,618,424.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920010898/0001567619-20-010898-index.htm
2020-10-16SUMMER ROAD LLC10% Share HolderBuy437.0010.484,579.765,618,861.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920017996/0001567619-20-017996-index.htm
2019-06-04Amarpreet SawhneyChairman of the BoardBuy12,928.002.9237,749.76898,711.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-05Amarpreet SawhneyChairman of the BoardBuy32,852.002.9195,599.32931,563.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-06Antony C. MattessichPresident & CEOBuy40,000.002.81112,400.0097,900.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034632/0001104659-19-034632-index.htm
2019-06-06Amarpreet SawhneyChairman of the BoardBuy59,000.002.80165,200.00990,563.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm